Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast CancerBusiness Wire
LLB Group profit at previous year’s levelEQS Newswire
EQS-News: Annual Report 2025: BB Biotech delivers strong performance and portfolio value realizationEQS Newswire
Henriette Mersebach fratræder som forskningsdirektør i ALKGlobeNewswire
Henriette Mersebach to step down as ALK’s head of R&DGlobeNewswire
DANONE: 2025: Another year of strong deliveryGlobeNewswire
Danone réalise à nouveau une forte performance en 2025GlobeNewswire
BW Offshore: Invitation to Q4 2025 Presentation 27 FebruaryGlobeNewswire
BOURSE DIRECT :   2025 Produits d’exploitation bancaire consolidés : 77,2m€ Résultat d’exploitation consolidé de 26,7 m€(+2,4%) Résultat net–part du groupe à 19,7 m€ (+3,2%)   Proposition d’un dividende de 24 centimes par action (+20%)GlobeNewswire
Umicore : Résultats Annuels 2025GlobeNewswire
Umicore: Jaarresultaten 2025GlobeNewswire
Umicore: Full Year Results 2025GlobeNewswire
Brunel Q4 2025 results: Stabilising performance with increased efficiencyGlobeNewswire
COMMUNIQUE DE PRESSE: BIGBEN annonce la suspension temporaire du cours de ses actions sur Euronext Paris et de ses obligations sur Euronext Access ParisGlobeNewswire
PRESS RELEASE: BIGBEN announces the temporary suspension of trading in its shares on Euronext Paris and its bonds on Euronext Access ParisGlobeNewswire
COMMUNIQUE DE PRESSE: NACON annonce la suspension temporaire du cours de ses actions sur Euronext ParisGlobeNewswire
PRESS RELEASE: NACON announces the temporary suspension of trading in its shares on Euronext ParisGlobeNewswire
Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT marginGlobeNewswire
dsm-firmenich publishes 2025 Integrated Annual ReportGlobeNewswire
RNS announcements are delayed by up to an hour.
...